New diabetes clinical trial: Pre-meals of 3-hydroxybutyrate in Type 2 Diabetes

Published on: October 14, 2022 at 11:00AM
Conditions:   Ketosis;   Postprandial Hyperglycemia;   Glucose Metabolism Disorders (Including Diabetes Mellitus)
Intervention:   Dietary Supplement: 3-hydroxybutyrate (3-OHB)
Sponsors:   University of Aarhus;   Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark;   Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark
Recruiting
https://ift.tt/KLFg74c